Cytochrome P450 CYP1A1 accumulates in the cytosol of kidney and brain and is activated by heme

Molecular Pharmacology

Volumn 62, Issue 5, 2002, Pages 1061-1067

  Meyer, Ralf Peter ^a,b   Podvinec, Michael ^a   Meyer, Urs A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Neurocenter   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME; CYTOCHROME P450 1A1; ETHOXYRESORUFIN; ETHOXYRESORUFIN DEETHYLASE; HEMATIN; HEME DERIVATIVE; MONOCLONAL ANTIBODY; SUCCINYLACETONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN MICROSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DRUG METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOBLOTTING; IN VITRO STUDY; KIDNEY; KIDNEY MICROSOME; LIVER; MALE; MOUSE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; BRAIN; COS CELLS; CYTOCHROME P-450 CYP1A1; CYTOSOL; ENZYME ACTIVATION; HAPLORHINI; HEME; HEMIN; IMMUNOBLOTTING; KIDNEY; LIVER; MALE; MICE; OXAZINES; SUBCELLULAR FRACTIONS;

EID: 0036839755     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.5.1061     Document Type: Article

References (42)

1. Bonkovsky HL, Healey JF, Lourie AN, and Gerron GG (1991) Intravenous hemealbumin in acute intermittent porphyria: Evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol 86:1050-1056.
2. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, and Mayer RT (1985) Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337-3345.
3. Carvalho H, Bechara EJ, Meneghini R, and Demasi M (1997) Haem precursor delta-aminolaevulinic acid induces activation of the cytosolic iron regulatory protein 1. Biochem J 328:827-832.
4. Correia MA and Meyer UA (1975) Apocytochrome P-450: Reconstitution of functional cytochrome with hemin in vitro. Proc Natl Acad Sci USA 72:400-404.
5. Correira MA (1995) Rat and human liver cytochromes P450; substrate and inhibitor specificities and functional markers, in Cytochrome P450: Structure, Mechanism and Biochemistry (Ortiz de Montellano PR ed) pp 607-630, Plenum Press, New York.
6. Cullen BR (1987) Use of eucaryotic technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704.
7. da Silva JL, Zand BA, Yang LM, Sabaawy HE, Lianos E, and Abraham NG (2001) Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int 59:1448-1457.
8. de Groot MJ, Vermeulen NP, Kramer JD, van Acker FA, and Donne-Op den Kelder GM (1996) A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102 and P450 108. Chem Res Toxicol 9:1079-1091.
9. Doostzadeh J, Urban P, Pompon D, and Morfin R (1996) Pregnenolone-7 betahydroxylating activities of yeast-expressed mouse cytochrome P450-1A1 and mouse-tissue microsomes. Eur J Biochem 242:641-647.
10. Giger U and Meyer UA (1983) Effect of succinylacetone on heme and cytochrome P450 synthesis in hepatocyte culture. FEBS Lett 153:335-338.
11. Gu J, Zhang QY, Genter MB, Lipinskas TW, Negishi M, Nebert DW, and Ding X (1998) Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1: Role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes. J Pharmacol Exp Ther 285:1287-1295.
12. Hedlund E, Wyss A, Kainu T, Backlund M, Kohler C, Pelto-Huikko M, Gustafsson JA, and Warner M (1996) Cytochrome P4502D4 in the brain: Specific neuronal regulation by clozapine and toluene. Mol Pharmacol 50:342-50.
13. Huang P, Rannug A, Ahlbom E, Hakansson H, and Ceccatelli S (2000) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary. Toxicol Appl Pharmacol 169:159-167.
14. Ingi T, Chiang G, and Ronnett G V (1996) The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci 16:5621-5628.
15. Iscan M, Reuhl K, Weiss B, and Maines MD (1990) Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: The olfactory bulb and the mitochondrial fraction have high levels of activity. Biochem Biophys Res Commun 169:858-863.
16. Joseph P and Jaiswal AK (1994) NAD(P)H: Quinone oxidoreductasel (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-dna adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 91:8413-8417.
17. 2+-chelate affinity purification and characterization of solubility and aggregation. Arch Biochem Biophys 321:277-288.
18. Kimura S, Gonzalez FJ, and Nebert DW (1984) The murine Ah locus, comparison of the complete cytochrome P1-450 and P3-450 cDNA nucleotide and amino acid sequences. J Biol Chem 259:10705-10713.
19. Lohr JW, Willsky GR, and Acara MA (1998) Renal drug metabolism. Pharmacol Rev 50:107-141.
20. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
21. Meyer RP, Knoth R, Schiltz E, and Volk B (2001) Possible function of astrocyte cytochrome P450 in control of xenobiotic phenytoin in the brain: In vitro studies on murine astrocyte primary cultures. Exp Neurol 167:376-384.
22. Meyer UA, Schuurmans MM, and Lindberg RL (1998) Acute porphyrias: Pathogenesis of neurological manifestations. Semin Liver Dis 18:43-52.
23. Näslund BMA, Glauman H, Warner M, Gustafsson JA, and Hansson T (1988) Cytochrome P450 b and c in the rat brain and the pituitary gland. Mol Pharmacol 33:31-37.
24. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, et al. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
25. Neunaber R and Achazi RK (1999) A novel, endogenous inhibitor of 7-ethoxyresorufin-O-deethylase activity isolated from liver cytosolic fractions of bream (Abramis brama L.). Comp Biochem Physiol Part B Comp Biochem Mol Biol 124:89-100.
26. Omiecinski CJ, Bond JA, and Juchau MR (1978) Stimulation by hematin of monooxygenase activity in extra-hepatic tissues from rats, rabbits and chickens. Biochem Biophys Res Commun 83:1004-1011.
27. Omiecinski CJ, Namkung MJ, and Juchau MR (1980) Mechanistic aspects of the hematin-mediated increases in brain monooxygenase activities. Mol Pharmacol 17:255-232.
28. Park SS, Fujino T, Guengerich FP, and Gelboin HV (1982) Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450. Cancer Res 42:1798-1808.
29. Pinnix IB, Guzman GS, Bonkovsky HL, Zaki SR, and Kinkade JMJ (1994) The post-translational processing ofmyeloperoxidase is regulated by the availability of heme. Arch Biochem Biophys 312:447-458.
30. Poinas A, Gaillard J, Vignais P, and Doussiere J (2002) Exploration of the diaphorase activity of neutrophil NADPH oxidase. Eur J Biochem 269:1243-1252.
31. Reed CJ, Lock EA, and De Matteis F (1988) Olfactory cytochrome P-450. Studies with suicide substrates of the haemoprotein. Biochem J 253:569 -576.
32. Riedl AG, Watts PM, Jenner P, and Marsden CD (1998) P450 enzymes and Parkinson's disease: The story so far. Mov Disord 13:212-220.
33. Rosenbrock H, Hagemeyer CE, Ditter M, Knoth R, and Volk B (2001) Expression and localization of the CYP2B subfamily predominantly in neurones of rat brain. J Neurochem 76:332-340.
34. Rosenbrock H, Hagemeyer CE, Singe I, Knoth R, and Volk B (1999) Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms. J Neuroendocrinol 11:597-604.
35. Schilter B and Omiecinski CJ (1993) Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase MRNAs in the rat brain. Mol Pharmacol 44:990-996.
36. Shahi GS, Das NP, and Moochhala SM (1991) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: Partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by betanaphthoflavone-pretreatment. Neurosci Lett 127:247-250.
37. Strobel HW, Geng J, Kawashima H, and Wang H (1997) Cytochrome P450-dependent biotransformation of drugs and other xenobiotic substrates in neural tissue. Drug Metab Rev 29:1079-1105.
38. Taylor KL, Guzman GS, Burgess CA, and Kinkade JM Jr (1990) Assembly of dimeric myeloperoxidase during posttranslational maturation in human leukemic HL-60 cells. Biochemistry 29:1533-1539.
39. Vijayasarathy C, Damle S, Lenka N, and Avadhani NG (1999) Tissue variant effects of heme inhibitors on the mouse cytochrome c oxidase gene expression and catalytic activity of the enzyme complex. Eur J Biochem 266:191-200.
40. Volk B, Meyer RP, von Lintig F, Ibach B, and Knoth R (1995) Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms. Toxicol Lett 82-83:655-662.
41. Warner M, Hellmold H, Magnusson M, Rylander T, Hedlund E, and Gustafsson JA (1998) Extrahepatic cytochrome P450: Role in in situ toxicity and cell-specific hormone sensitivity. Arch Toxicol Suppl 20:455-463.
42. Yang Y, Zhang D, and Cerniglia CE (1997) Purification and characterization of a cytosolic cytochrome P450 from yeast trichosporon cutaneum. FEMS Microbiol Lett 154:347-353.